A new association called Cellular Agriculture Europe has been formed to represent the interests of the cultivated products industry. The association has just held its first General Assembly meeting, where a Board of Directors was elected. 13 member companies took part in the meeting, and the following Board was chosen: Chris Dammann, Chief Operating Officer of Bluu Biosciences. Etienne Duthoit, CEO and Co-Founder of Vital Meat. Robert E. Jones, Head of Public Affairs at Mosa Meat (elected President of the Board). Beth Loberant, Head of Regulatory Affairs at SuperMeat. Hélène Miller, Head of European Affairs at Aleph Farms. Participants at the meeting agreed that the mission of Cellular Agriculture Europe would be to bring together stakeholders and producers of cultivated products and ingredients, finding a …
The European Parliament has voted to proceed with its Farm to Fork Strategy, putting plans in motion for an environmentally-friendly food system with higher animal welfare standards. The move has been opposed by agribusiness lobbyists, but MEPs voted in favour of the plan which may eventually put a stop to some of the horrors of intensive animal agriculture. “This strategy has the potential to bring our food system back within planetary boundaries by moving away from intensive livestock farming and towards more plant-based foods” – Jasmijn De Boo, ProVeg International When in place, the Farm to Fork Strategy would trigger a shift away from intensive factory farming, backed up by the EU’s recent historic commitment to phase out cages in animal farming throughout the bloc. …
Further to last week’s release of the European Commission’s Farm to Fork Strategy, various individuals and companies are speaking out about their disappointment in this policy. Dr. Jeanette Fielding from Upfield, the largest plant-based consumer product company in the world, here gives her views.
The European Commission has released its Farm to Fork Strategy, the flagship initiative under the new European Green Deal, outlining financial support of at least €100 billion over the period 2021-2027 for the green transition, and pledging to make alternative proteins a cornerstone of its research agenda as part of the green transition.
